Robert McCarthy, PhD

5 Riverside Drive, Apt 17C

New York, NY 10023

646-269-1554

Email: robertfgmccarthy@gmail.com

PROFESSIONAL EXPERIENCE:

2015-- Scientific Director, Medscape Education

Responsible for the development of CME programs for the Medscape Ex-

USA website, with particular emphasis on cardiometabolic disorders,

rheumatology, and neurology

2015--2015 Medical Comms Program Direction/Medical Writing Services

Clients include Med-Val, Unified/Wild Type, AdelphiGroup US

2012—2014 Vice President, Medical Director, Edelman Bioscience

Scientific lead:

Secukinumab, a cytokine inhibitor in development by Novartis for a range of

autoimmune disorders (eg, psoriasis, psoriatic arthritis, arthritides, uveitis,

Crohn’s disease, MS).

Responsible for development/delivery of all scientific content, including

o strategy, tactics, and execution of med comms plans and publications

plans (Phase 3 data Ms recently accepted by NEJM)

o extensive work on primary publications (Phase 3 trials), reviews,

abstracts/posters

o extensive work on symposia content; MSL training content; advisory board content; Congress booth panel content

Please see pages 3-7 of the resume for a more detailed account of therapeutic category/agent experience

2008-2012 Director, Scientific Services, Adelphi US

Scientific lead:

Liraglutide, a GLP-1 receptor agonist developed by Novo Nordisk and approved as Victoza, for the treatment of Type 2 diabetes

Riociguat, a soluble guanylate cyclase stimulator developed by Bayer, for the treatment of pulmonary hypertension

Kogenate, a recombinant Factor VIII replacement therapy, developed and marketed by Bayer, for the treatment of hemophilia-Type A

Faldaprevir, a protease inhibitor developed by Boehringer Ingelheim, for the treatment of hepatitis C

Oversaw project work on a range of other compounds and devices, including vedolizumab, α4β7 integrin antagonist in development for Crohn’s disease and ulcerative colitis; donepezil (Aricept), an acetylcholinesterase inhibitor, indicated for Alzheimer’s disease; and the Ethicon harmonic knife, for endoscopic surgery

Responsible for development/delivery of all scientific content, including strategy, tactics, and execution of med comms plans and publications plans. Worked extensively on primary publications (Phase 3 trials), reviews, abstracts/posters; symposia content; MSL training content.

Managed a staff of medical writers and editors (that varied in size from 3 to 5 med writers editors), as well as freelance contractors

o Apportioned workloads, reviewed work product, determined hours required to complete projects,

o Provided leadership in mentoring staff development by helping to set goals and assess acquisition of new skills

2003-2008 Manager, Medical Writing, EURO RSCG Genecom (Havas)

Responsible for oversight and production of medical

communications/publications for such compounds as

o Tekturna and Diovan (Novartis, hypertension);

o Avandia, Lantus (GSK, diabetes);

o Actos (Takada, diabetes);

o Lovenox (Aventis, DVT);

o Rimonabant (Sanofi, weight loss);

o Lunesta (Sunovion, insomnia);

o Xopenex (Sunovion, asthma)

Managed Genecom’s medical writing group (in-house personnel and freelance;

varied in size from 2 to 5 med writers editors)

o Apportioned workloads, reviewed work product, determined hours required to complete projects,

o Provided leadership in mentoring staff development by helping to set goals and assess acquisition of new skills

In the 1990s I worked as a healthcare journalist specializing in managed care/managed

markets. I was for 3 years the managing editor of Business and Health magazine. I

wrote for a number of publications the covered the business of healthcare provision,

including Managed Care Today, Drug-Benefit Trends, and Drug Topics. For a number

of years I wrote two newsletters: 3rd Party Pharmacy and Managed Care Digest. In the

early ‘90s I researched and wrote what was probably among the first white papers on

disease-state management for the healthcare division of what was then

PriceWaterhouseCoopers.

Please see attached CV for a more comprehensive discussion of agency work/life

experience

EDUCATION PhD, English, Rutgers University

MA, English, Rutgers University

BA, Philosophy, King’s College